CTRI/2026/07/113990进行中（未招募）不适用
A Study To Evaluate Efficacy Of Individualised Homoeopathic Medicines In Management Of Psoriasis Using Boger Boenninghausens Characteristics And Repertory - nil
Ahmedabad Homoeopathic Medical College attached to Sainath Hospital0 个研究点目标入组 35 人开始时间: 2026年7月27日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of both sexes and aged between 20 to 60 years will be included for study. 2.Any Individuals belonging to any religion, socioeconomic background, or occupation diagnosed with psoriasis or pre-diagnosed will be included for study. 3.Patient willing to give written consent.
排除标准
- •1.Patients who have psoriasis complicated with other skin diseases and joint disease like arthritis, myopathy, etc., will be excluded from the study.
- •2.Patients suffering from psoriasis who have other systemic illnesses, irreversible pathologies, or are resistant cases due to excessive use of steroids will be excluded. 3.Patients having any psychiatric illness.
- •4.Pregnant and lactation female will be excluded.
- •5.According to, Dermatology Life Quality Index, more than 21 score will not be included.
研究者
相似试验
进行中（未招募）
不适用
Improvement of Abnormal Vaginal Discharge in Women Using Individualized Homoeopathic TreatmentCTRI/2026/07/114139Ahmedabad Homeopathic Medical College40
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
招募中
不适用
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease (J2A-MC-GZPR)Peripheral Arterial DiseasejRCT20312505701,205
尚未招募
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on
Background Insulin (Eluminate-3)Type 2 Diabetes MellitusjRCT203126026280
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)Type 2 Diabetes MellitusjRCT2031260261165